US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

261.85

-0.4300-0.16%

Post-market: 261.850.00000.00%19:30 EDT

Volume:30.06K

Turnover:7.90M

Market Cap:2.84B

PE:30.64

High:264.97

Open:264.46

Low:261.85

Close:262.28

52wk High:274.99

52wk Low:173.98

Shares:10.85M

Float Shares:10.85M

Volume Ratio:0.98

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.02

PE(LYR):6.94

Loading ...

Overview Company News Filings

Corcept Therapeutics to Announce Second Quarter Financial Results

Corcept Therapeutics Schedules Second-quarter Results Conference Call

How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors

Simply Wall St.

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS

Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation

NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care

Neogenomics Settlement Comes in Under Accrued Reserves

Neogenomics Resolves DOJ Investigation

NeoGenomics announces settlement of voluntary disclosure to OIG-HHS

Neogenomics Agrees to Pay USD 9.81 Million to Settle DOJ Probe Tied to Lab Collaboration Program

Neogenomics - to Pay $9.81 Mln Plus 4.25% Interest from Jan 16, 2026 to Resolve Matter

THOMSON REUTERS

Neogenomics - Finalizes Civil Settlement with DOJ and Oig Resolving Investigation

THOMSON REUTERS

Neogenomics Announces Settlement of Voluntary Disclosure to Oig-hhs

THOMSON REUTERS

Alkermes Plc : Stifel Raises Target Price to $63 from $45

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)

Xi'an Jiaotong University Receives Another Anonymous Donation, This Time Totaling 30 Million Yuan

International Student Deceives Elderly Parents into Borrowing Millions, Sentenced to 11 Years for Fraud

Corcept Therapeutics (CORT) Stock Could Trade At A Discount As Its 346% Run Looms

Simply Wall St.

Corcept Therapeutics CFO Atabak Mokari Disposes of 40,000 Common Shares for $3.52 Million

Can Veracyte (VCYT) Stay Reasonable After A 145% Rally?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/FBT/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":261.85,"timestamp":1789156800000,"preClose":262.28,"halted":0,"volume":30061,"hourTrading":{"tag":"盘后","latestPrice":261.85,"preClose":261.85,"latestTime":"19:30 EDT","volume":15,"amount":3926.22,"timestamp":1789169408690,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0016394692694828047,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Market Closed","change":-0.43,"latestTime":"09-11 16:00:00 EDT","open":264.46,"high":264.965,"low":261.85,"amount":7900544.843099999,"amplitude":0.011877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":262.28,"sharesOutstanding":11450002,"nav":262.39,"aum":2860051524.78,"bidAskSpread":0.001063,"preHourTrading":{"tag":"盘前","latestPrice":262.28,"preClose":262.28,"latestTime":"08:18 EDT","volume":1,"amount":262.28,"timestamp":1789129101219,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":261.85,"preClose":261.85,"latestTime":"19:30 EDT","volume":15,"amount":3926.22,"timestamp":1789169408690,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9828931233249508,"impliedVol":0.2371,"impliedVolPercentile":0.8725},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.9828931233249508,"shares":10850002,"dividePrice":0,"high":264.965,"amplitude":0.011877,"preClose":262.28,"low":261.85,"week52Low":173.975,"pbRate":"1.02","psRate":"685.38","week52High":274.99,"institutionHeld":0,"latestPrice":261.85,"eps":8.545272,"divideRate":0,"volume":30061,"delay":0,"ttmEps":8.545272,"open":264.46,"prevYearClose":206.52,"prevWeekClose":270.93,"prevMonthClose":267.15,"prevQuarterClose":247.89,"fiveDayClose":273.79,"twentyDayClose":256.07,"sixtyDayClose":226.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653799128","title":"Corcept Therapeutics to Announce Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653799128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653799128?lang=en_us&edition=fundamental","pubTime":"2026-07-23 06:00","pubTimestamp":1784757602,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Therapeutics To Announce Second Quarter Financial ResultsJuly 22 (Reuters)-Corcept Therapeutics IncCORT.O:CORCEPT THERAPEUTICS TO ANNOUNCE SECOND QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALLSource text:ID:nBw7GQVldaFurther company coverage:CORT.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA2QJWLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","LU1559883803.SGD","BK4532","CORT","FBT","LU0566484027.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653798193","title":"Corcept Therapeutics Schedules Second-quarter Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653798193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653798193?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:05","pubTimestamp":1784750729,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics schedules second-quarter results conference callCorcept set July 29, 2026 to report second-quarter financial results, issue a corporate update, host a conference call at 5 p.m. ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL1V8Pdx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","PSCH","BK4532","LU0566484027.USD","LU1559883803.SGD","CORT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653013712","title":"How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653013712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653013712?lang=en_us&edition=fundamental","pubTime":"2026-07-21 22:27","pubTimestamp":1784644055,"startTime":"0","endTime":"0","summary":"In June 2026, NeoGenomics finalized a civil settlement with the U.S. Department of Justice, agreeing to pay US$9,813,260 plus interest to resolve an investigation into consulting arrangements, having previously reserved US$11,200,000 for potential liabilities.\nSeparately, the company launched PTEN IHC CDx, the first FDA-approved immunohistochemistry companion diagnostic for PTEN-deficient prostate adenocarcinoma, expanding its role in targeted prostate cancer care.\nWe’ll now examine how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-doj-settlement-resolution-and-new-pten-cdx-launch-will-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-doj-settlement-resolution-and-new-pten-cdx-launch-will-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","FBT","NEO","BK4121","BK4092","BK4196","LU0012050646.USD","LU0106261612.USD","BK4211","PTEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277231","title":"Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277231?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:34","pubTimestamp":1784637260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","FBT","MEDX","PSCH","PSIL","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249601","title":"Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249601","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249601?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:59","pubTimestamp":1784584740,"startTime":"0","endTime":"0","summary":"NeoGenomics agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act.The Justice Department alleged that the cancer diagnostics company provided laboratory consulting se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","NEO","LU0012050646.USD","FBT","BK4196","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653494062","title":"NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2653494062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653494062?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:47","pubTimestamp":1784584059,"startTime":"0","endTime":"0","summary":"NeoGenomics ( ($NEO) ) just unveiled an update. On June 20, 2026, NeoGenomics finalized a civil settlement with the U.S. Department of Justice, act...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neogenomics-resolves-doj-investigation-refocuses-on-cancer-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neogenomics-resolves-doj-investigation-refocuses-on-cancer-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","LU0106261612.USD","BK4121","FBT","LU0012050646.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249572","title":"Neogenomics Settlement Comes in Under Accrued Reserves","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249572","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249572?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:46","pubTimestamp":1784583960,"startTime":"0","endTime":"0","summary":"NeoGenomics finalized a civil settlement with the Department of Justice, resolving an investigation into consulting services the company provided to health care providers through its Laboratory Collaboration Initiative. The settlement of $9.8 million, plus interest at a rate of 4.25%, falls below the $11.2 million in reserves the company previously disclosed in SEC filings. NeoGenomics is set to report second-quarter results on July 28.This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 20, 2026 17:46 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","LU0012050646.USD","FBT","BK4196","BK4121","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249504","title":"Neogenomics Resolves DOJ Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249504?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:46","pubTimestamp":1784583960,"startTime":"0","endTime":"0","summary":"The $9.8 million settlement NeoGenomics reached with the DOJ traces back to a voluntary disclosure the company made to the Office of Inspector General of the U.S. Department of Health and Human Services in Nov. 2021. The investigation centered on consulting services tied to laboratory testing under the company's Laboratory Collaboration Initiative program. The DOJ acknowledged in the settlement agreement that NeoGenomics cooperated with the government's investigation. The agreement isn't an admission of liability by the company nor a concession by the government that its claims lacked merit.This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 20, 2026 17:46 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","FBT","BK4121","NEO","BK4196","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249533","title":"NeoGenomics announces settlement of voluntary disclosure to OIG-HHS","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249533?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:30","pubTimestamp":1784583016,"startTime":"0","endTime":"0","summary":"NeoGenomics (NEO) has finalized a civil settlement with the Department of Justice, or DOJ, on behalf of the Office of Inspector General of the U.S....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neogenomics-announces-settlement-of-voluntary-disclosure-to-oig-hhs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neogenomics-announces-settlement-of-voluntary-disclosure-to-oig-hhs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4009","HHS","BK4129","LU0106261612.USD","LU0012050646.USD","NEO","BK4196","BK4121","FBT","OIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653124607","title":"Neogenomics Agrees to Pay USD 9.81 Million to Settle DOJ Probe Tied to Lab Collaboration Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2653124607","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653124607?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582611,"startTime":"0","endTime":"0","summary":"NeoGenomics agrees to pay USD 9.81 million to settle DOJ probe tied to lab collaboration programNeoGenomics reached a civil settlement with the U.S. Department of Justice on behalf of OIG-HHS, resolvi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL1SxqG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","FBT","LU0106261612.USD","LU0012050646.USD","NEO","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653460202","title":"Neogenomics - to Pay $9.81 Mln Plus 4.25% Interest from Jan 16, 2026 to Resolve Matter","url":"https://stock-news.laohu8.com/highlight/detail?id=2653460202","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653460202?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA4GJSKW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","NEO","LU0012050646.USD","BK4196","LU0106261612.USD","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653246073","title":"Neogenomics - Finalizes Civil Settlement with DOJ and Oig Resolving Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653246073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653246073?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA4GJSKW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","LU0012050646.USD","BK4196","LU0106261612.USD","BK4121","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653246022","title":"Neogenomics Announces Settlement of Voluntary Disclosure to Oig-hhs","url":"https://stock-news.laohu8.com/highlight/detail?id=2653246022","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653246022?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582580,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA4GJSKW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEO","BK4196","FBT","BK4121","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652290391","title":"Alkermes Plc : Stifel Raises Target Price to $63 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2652290391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652290391?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:09","pubTimestamp":1784545792,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","PSCH","ALKS","FBT","BK4139","PSIL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652329784","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652329784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652329784?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:30","pubTimestamp":1784543447,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harmony Biosciences Holdings (HRMY) and Alkermes (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PSIL","LABU","ALKS","BK4581","BK4588","LU0128526141.USD","BK4585","BK4137","XLV","PSCH","FBT","IBRN","LU0029874061.USD","HRMY","MEDX","XBI","HCSG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130409446","title":"Xi'an Jiaotong University Receives Another Anonymous Donation, This Time Totaling 30 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1130409446","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130409446?lang=en_us&edition=fundamental","pubTime":"2026-07-19 08:10","pubTimestamp":1784419854,"startTime":"0","endTime":"0","summary":"China's National Development and Reform Commission has allocated 30 million yuan to support emergency recovery efforts following the mountain landslide disaster in Chongqing.The Ministry of Water...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO","LU0012050646.USD","BK4121","FBT","BK4196","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198798316","title":"International Student Deceives Elderly Parents into Borrowing Millions, Sentenced to 11 Years for Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=1198798316","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198798316?lang=en_us&edition=fundamental","pubTime":"2026-07-19 08:10","pubTimestamp":1784419852,"startTime":"0","endTime":"0","summary":"Here are the key news items from the past 24 hours.The National Development and Reform Commission has allocated 30 million yuan to support emergency recovery efforts following a mountain collapse...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO","BK4121","LU0012050646.USD","LU0106261612.USD","BK4196","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652345692","title":"Corcept Therapeutics (CORT) Stock Could Trade At A Discount As Its 346% Run Looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2652345692","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652345692?lang=en_us&edition=fundamental","pubTime":"2026-07-18 19:24","pubTimestamp":1784373847,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics has delivered very strong long term share price gains over the past five years, yet its latest valuation checks lean more cautious, leaving investors weighing a powerful performance track record against a weak overall value score.\n\nCorcept Therapeutics is up about 346.1% over five years, which puts the recent share price in the context of a very strong run already behind it.\nProgress with cortisol modulating drugs, including Lifyorli and the resubmitted relacorilant...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-trade-at-a-discount-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-trade-at-a-discount-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","PSCH","CORT","LU0566484027.USD","FBT","BK4007","LU1559883803.SGD","TSPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652233480","title":"Corcept Therapeutics CFO Atabak Mokari Disposes of 40,000 Common Shares for $3.52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2652233480","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652233480?lang=en_us&edition=fundamental","pubTime":"2026-07-18 06:32","pubTimestamp":1784327541,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics CFO Atabak Mokari disposes of 40,000 common shares for $3.52 millionCorcept Therapeutics CFO Atabak Mokari exercised stock options on July 15, 2026, acquiring 40,000 common shares","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL4tTLkC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Therapeutics CFO Atabak Mokari Disposes of 40,000 Common Shares for $3.52 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","BK4532","FBT","CORT","LU1559883803.SGD","BK4007","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652786214","title":"Can Veracyte (VCYT) Stay Reasonable After A 145% Rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=2652786214","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652786214?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:34","pubTimestamp":1784241286,"startTime":"0","endTime":"0","summary":"Veracyte’s share price has climbed sharply over the past year, yet the valuation checks are pulling in different directions. An intrinsic value estimate based on a Discounted Cash Flow (DCF) suggests the stock trades below that estimate, while market multiples lean expensive and the broader score is weak.\n\nVeracyte has returned 144.5% over the past year, which puts extra focus on whether recent gains already reflect the company’s prospects.\nRising earnings estimates and growth plans in areas...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/can-veracyte-vcyt-stay-reasonable-after-a-145-rally","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/can-veracyte-vcyt-stay-reasonable-after-a-145-rally","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","FEBU","GXDW","VGFPF","VCYT","DCF","FBT","DECU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}